Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Monopar Therapeutics (MNPR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
14 Nov 2022
Cittadine Andrew
Chief Operating Officer, Officer
Monopar Therapeutics
(MNPR)
24,238
+196%
16,053
$3.09
$49,659.00
SELL
11 Feb 2021
Tactic Pharma LLC
10% Owner
Monopar Therapeutics
(MNPR)
249,200
-33%
125,000
$14.64
$1,830,619.90
BUY
18 Dec 2019
Leo Karl
10% Owner
Monopar Therapeutics
(MNPR)
156,250
+49900%
156,563.75
$8.00
$1,252,510.00
BUY
18 Dec 2019
Tactic Pharma LLC
10% Owner
Monopar Therapeutics
(MNPR)
291,667
+74%
125,000
$8.00
$1,000,000.00
BUY
18 Dec 2019
Tsuchimoto Kim R
Chief Financial Officer, Officer
Monopar Therapeutics
(MNPR)
325
+100%
325
$8.00
$2,600.00
BUY
18 Dec 2019
Hendricks Diane
10% Owner
Monopar Therapeutics
(MNPR)
468,750
+100%
468,750
$8.00
$3,750,000.00
Home